127 related articles for article (PubMed ID: 35279470)
1. Impact of diabetes and metformin use on recurrence and outcome in stage II-III colon cancer patients-A pooled analysis of three adjuvant trials.
Christou N; Bergen ES; Canton C; Le Malicot K; Di Bartolomeo M; Galli F; Galli F; Labianca R; Shi Q; Alberts SR; Goldberg RM; Lepage C; Sinicrope FA; Taieb J
Eur J Cancer; 2022 May; 166():100-111. PubMed ID: 35279470
[TBL] [Abstract][Full Text] [Related]
2. Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance).
Singh PP; Shi Q; Foster NR; Grothey A; Nair SG; Chan E; Shields AF; Goldberg RM; Gill S; Kahlenberg MS; Sinicrope FA; Sargent DJ; Alberts SR
Oncologist; 2016 Dec; 21(12):1509-1521. PubMed ID: 27881709
[TBL] [Abstract][Full Text] [Related]
3. Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.
Vernieri C; Galli F; Ferrari L; Marchetti P; Lonardi S; Maiello E; Iaffaioli RV; Zampino MG; Zaniboni A; De Placido S; Banzi M; Damiani A; Ferrari D; Rosati G; Labianca RF; Bidoli P; Frassineti GL; Nicolini M; Pavesi L; Tronconi MC; Buonadonna A; Ferrario S; Re GL; Adamo V; Tamburini E; Clerico M; Giordani P; Leonardi F; Barni S; Ciarlo A; Cavanna L; Gori S; Cinieri S; Faedi M; Aglietta M; Antista M; Dotti KF; Galli F; Di Bartolomeo M;
Oncologist; 2019 Mar; 24(3):385-393. PubMed ID: 30606884
[TBL] [Abstract][Full Text] [Related]
4. Metformin is associated with improved survival in endometrial cancer.
Ko EM; Walter P; Jackson A; Clark L; Franasiak J; Bolac C; Havrilesky LJ; Secord AA; Moore DT; Gehrig PA; Bae-Jump V
Gynecol Oncol; 2014 Feb; 132(2):438-42. PubMed ID: 24269517
[TBL] [Abstract][Full Text] [Related]
5. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF
Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245
[TBL] [Abstract][Full Text] [Related]
6. Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer.
Rieken M; Kluth LA; Xylinas E; Fajkovic H; Becker A; Karakiewicz PI; Herman M; Lotan Y; Seitz C; Schramek P; Remzi M; Loidl W; Pummer K; Lee RK; Faison T; Scherr DS; Kautzky-Willer A; Bachmann A; Tewari A; Shariat SF
World J Urol; 2014 Aug; 32(4):999-1005. PubMed ID: 24062093
[TBL] [Abstract][Full Text] [Related]
7. Impact of Diabetes on the Outcomes of Patients With Castration-resistant Prostate Cancer Treated With Docetaxel: A Pooled Analysis of Three Phase III Studies.
Abdel-Rahman O
Clin Genitourin Cancer; 2019 Feb; 17(1):e104-e112. PubMed ID: 30341029
[TBL] [Abstract][Full Text] [Related]
8. Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Rieken M; Xylinas E; Kluth L; Trinh QD; Lee RK; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Kautzky-Willer A; Bachmann A; Shariat SF;
Eur J Surg Oncol; 2014 Jan; 40(1):113-20. PubMed ID: 24113620
[TBL] [Abstract][Full Text] [Related]
9. Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Fajkovic H; Babjuk M; Kautzky-Willer A; Bachmann A; Scherr DS; Shariat SF
BJU Int; 2013 Dec; 112(8):1105-12. PubMed ID: 24053906
[TBL] [Abstract][Full Text] [Related]
10. [The effect of metformin on responses to chemotherapy and survival in stage IV colorectal cancer with diabetes].
Lee DJ; Kim B; Lee JH; Park SJ; Hong SP; Cheon JH; Kim TI; Kim WH
Korean J Gastroenterol; 2012 Dec; 60(6):355-61. PubMed ID: 23242018
[TBL] [Abstract][Full Text] [Related]
11. The effect of metformin on the survival of colorectal cancer patients with type 2 diabetes mellitus.
Tarhini Z; Manceur K; Magne J; Mathonnet M; Jost J; Christou N
Sci Rep; 2022 Jul; 12(1):12374. PubMed ID: 35859114
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy.
Choi Y; Kim TY; Oh DY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
Cancer Res Treat; 2016 Jan; 48(1):171-9. PubMed ID: 25779362
[TBL] [Abstract][Full Text] [Related]
13. Metformin Has Positive Therapeutic Effects in Colon Cancer and Lung Cancer.
Henderson D; Frieson D; Zuber J; Solomon SS
Am J Med Sci; 2017 Sep; 354(3):246-251. PubMed ID: 28918830
[TBL] [Abstract][Full Text] [Related]
14. Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials.
Schmoll HJ; Twelves C; Sun W; O'Connell MJ; Cartwright T; McKenna E; Saif M; Lee S; Yothers G; Haller D
Lancet Oncol; 2014 Dec; 15(13):1481-1492. PubMed ID: 25456367
[TBL] [Abstract][Full Text] [Related]
15. Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer: A Secondary Analysis of the AVANT Trial.
Chibaudel B; Henriques J; Rakez M; Brenner B; Kim TW; Martinez-Villacampa M; Gallego-Plazas J; Cervantes A; Shim K; Jonker D; Guerin-Meyer V; Mineur L; Banzi C; Dewdney A; Dejthevaporn T; Bloemendal HJ; Roth A; Moehler M; Aranda E; Van Cutsem E; Tabernero J; Schmoll HJ; Hoff PM; André T; de Gramont A
JAMA Netw Open; 2020 Oct; 3(10):e2020425. PubMed ID: 33074326
[TBL] [Abstract][Full Text] [Related]
16. Type 2 diabetes mellitus is associated with increased mortality in Chinese patients receiving curative surgery for colon cancer.
Chen KH; Shao YY; Lin ZZ; Yeh YC; Shau WY; Kuo RN; Chen HM; Lai CL; Yeh KH; Cheng AL; Lai MS
Oncologist; 2014 Sep; 19(9):951-8. PubMed ID: 25061090
[TBL] [Abstract][Full Text] [Related]
17. Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease.
Ho TW; Huang CT; Tsai YJ; Lien AS; Lai F; Yu CJ
Respir Res; 2019 Apr; 20(1):69. PubMed ID: 30953517
[TBL] [Abstract][Full Text] [Related]
18. Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer.
Garrett CR; Hassabo HM; Bhadkamkar NA; Wen S; Baladandayuthapani V; Kee BK; Eng C; Hassan MM
Br J Cancer; 2012 Apr; 106(8):1374-8. PubMed ID: 22421948
[TBL] [Abstract][Full Text] [Related]
19. Metformin use reduced the risk of stomach cancer in diabetic patients in Korea: an analysis of Korean NHIS-HEALS database.
Kim J; Hyun HJ; Choi EA; Kim Y; Bae YJ; Kang HT
Gastric Cancer; 2020 Nov; 23(6):1075-1083. PubMed ID: 32462322
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer trial.
Tournigand C; André T; Bonnetain F; Chibaudel B; Lledo G; Hickish T; Tabernero J; Boni C; Bachet JB; Teixeira L; de Gramont A
J Clin Oncol; 2012 Sep; 30(27):3353-60. PubMed ID: 22915656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]